Abstract:Developing stereoselective synthetic routes that are efficient and cost-effective allows easy access to biologically active molecules. Our previous syntheses of allele-selective bumped inhibitors of the Bromo and Extra-Terminal (BET) domain proteins, Brd2, Brd3, Brd4 and BrdT, required a wasteful, late-stage alkylation step and expensive chiral separation. To circumvent these limitations, we developed a route based on stereocontrolled alkylation of an N-Pf protected aspartic acid derivative that was used in a divergent, racemisation-free protocol to yield structurally diverse and enantiopure triazolodiazepines. With this approach, we synthesized bumped thienodiazepine-based BET inhibitor, ET-JQ1-OMe, in five steps and 99% ee without the need for chiral chromatography. Exquisite selectivity of ET-JQ1-OMe for Leu-Ala and Leu-Val mutants over wild-type bromodomain was established by isothermal titration calorimetry and X-ray crystallography. Our new approach provides unambiguous chemical evidence for the absolute stereochemistry of the active, allele-specific BET inhibitors and a viable route that will open wider access to this compound class.

Alternative Synthesis of Cobimetinib

Synthesis and Chiral Resolution of 2,2- Dimethylcyclopropane Carboxylic Acid

A Novel Asymmetric Synthesis of Cis-(3r, 4R)-N-(tert-butoxycarbonyl)-4-methyl-3-(methylamino) Piperidine

A Transition Metal-Free Approach to a Regioselective Total Synthesis of the Natural Product Derivative 6-Methylellipticine, a Potent Anticancer Agent

Improved Synthesis of Gefitinib

Catalytic Asymmetric Transfer Hydrogenation/dynamic Kinetic Resolution: an Efficient Synthesis of Florfenicol

Enantioselective Rhodium-Catalyzed Addition of Arylboroxines to N-Unprotected Ketimines: Efficient Synthesis of Cipargamin

An Efficient Synthesis of Ceritinib (LDK378) Using a Sandmeyer Reaction

Scalable total synthesis of a mycobactin T analogue utilizing a novel synthetic and protection strategy

Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036

An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94

Synthetic Studies on Camptothecins. Part 3

Asymmetric Total Synthesis of (20S)-Camptothecin Using a Chiral Auxiliary Strategy

A Facile Total Synthesis of Mubritinib

Toward Bicalutamide Analogues with High Structural Diversity Using Catalytic Asymmetric Oxohydroxylation

Biocatalytic Synthesis of a Key Chiral Delamanid Precursor using an Engineered P450 Monooxygenase

Synthesis of Nilotinib

Total Synthesis of Anti-Hiv Agent Chloropeptin I.

One-pot two-step catalytic synthesis of 6-amino-2-pyridone-3,5-dicarbonitriles enabling anti-cancer bioactivity

Synthesis of antitumor agent sunitinib malate

Stereoselective synthesis of allele-specific BET inhibitors